UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (date of earliest event reported):
May
8, 2009
CHEMED
CORPORATION
(Exact
name of registrant as specified in its charter)
Delaware |
1-8351 |
31-0791746 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
2600 Chemed Center, 255 East 5th Street, Cincinnati, OH 45202 |
(Address of principal executive offices) (Zip Code) |
Registrant’s
telephone number, including area code:
(513) 762-6900
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see General Instruction A.2 below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
On May 8, 2009 the Company’s VITAS subsidiary received an administrative subpoena from the U.S. Department of Justice requesting VITAS deliver to the Office of Inspector General documents, patient records, and policy and procedure manuals concerning hospice services provided by VITAS for the period January 1, 2003 to the present. Based on the early stage of this investigation and the limited information that we have at this time, the Company cannot predict the outcome of this investigation, the U.S. Attorney’s views of the issues being investigated, any actions that the U.S. Attorney may take or the impact, if any, that the investigation may have on our business, results of operations, liquidity or capital resources. We believe that we are in material compliance with the rules and regulations applicable to the Medicare and Medicaid hospice program.
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the Registrant
has caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
CHEMED CORPORATION |
||
|
|||
Dated: |
May 14, 2009 |
By: |
/s/ Arthur V. Tucker, Jr. |
Arthur V. Tucker, Jr. |
|||
Vice President and Controller |
Page 2 of 2